Summit Tx Capital, L.P. Summit Therapeutics Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 36,217 shares of SMMT stock, worth $853,996. This represents 0.03% of its overall portfolio holdings.
Number of Shares
36,217Holding current value
$853,996% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
237Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$576 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$274 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$186 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$155 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$114 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.74B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...